Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Stereotactic radiotherapy

  • You have access
    Radiotherapy for Bone Metastases in Patients With Excellent Performance Status: Patterns of Care and Prognostic Factors for Survival
    CARSTEN NIEDER, ELLINOR C. HAUKLAND, LUKA STANISAVLJEVIC and BÅRD MANNSÅKER
    Anticancer Research March 2025, 45 (3) 1149-1158; DOI: https://doi.org/10.21873/anticanres.17502
  • You have access
    A Rare Case of Brain Metastasis of Thymic Carcinoma
    TAKAAKI MITSUI, RYOSUKE MATSUDA, KAZUO GODA, HIROE ITAMI, ICHIRO NAKAGAWA and HIROYUKI NAKASE
    Anticancer Research February 2022, 42 (2) 1169-1174; DOI: https://doi.org/10.21873/anticanres.15582
  • You have access
    Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study
    DIMITRI ANZELLINI, VITALIANA DE SANCTIS, MAURIZIO VALERIANI, CHIARA REVERBERI, LUCA MARINELLI, MARIA MASSARO, GIANLUCA VULLO, GIUSEPPE FACONDO, RICCARDO CARLO SIGILLO, EMANUELE TOSI and MATTIA FALCHETTO OSTI
    Anticancer Research October 2021, 41 (10) 5107-5116; DOI: https://doi.org/10.21873/anticanres.15327
  • You have access
    Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM Score
    CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA
    Anticancer Research January 2021, 41 (1) 341-345; DOI: https://doi.org/10.21873/anticanres.14781
  • You have access
    Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World
    VITTORIO GEBBIA, ANDREA GIRLANDO, ALFIO DI GRAZIA, IVAN FAZIO, NICOLÒ BORSELLINO, DARIO PIAZZA, VINCENZO SERRETTA, STEFANO PERGOLIZZI, ANTONIO PONTORIERO, ALBERTO FIRENZE and MARIA ROSARIA VALERIO
    Anticancer Research December 2020, 40 (12) 7037-7043; DOI: https://doi.org/10.21873/anticanres.14730
  • You have access
    The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era
    LAITH SAMHOURI, JAN KRIZ, KHALED ELSAYAD, MOHAMMED CHANNAOUI, ANDREAS PASCHER, BURKHARD RIEMANN, RAINER WIEWRODT, UWE HAVERKAMP, SERGIU SCOBIOALA and HANS THEODOR EICH
    Anticancer Research June 2020, 40 (6) 3379-3386; DOI: https://doi.org/10.21873/anticanres.14321
  • You have access
    Occurrence of Seizures Prior to Single-fraction Radiosurgery or Multi-fraction Stereotactic Radiotherapy in Patients With Very Few Brain Metastases
    DIRK RADES, JASPAR WITTELER, TROELS W. KJAER, SOEREN TVILSTED and STEVEN E. SCHILD
    Anticancer Research June 2020, 40 (6) 3499-3504; DOI: https://doi.org/10.21873/anticanres.14337
  • You have access
    Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife
    KANA ADACHI, KAZUHIKO HAYASHI, NAOKI KAGAWA, MANABU KINOSHITA, IORI SUMIDA, YUICHI AKINO, HIROYA SHIOMI, KEISUKE TAMARI, OSAMU SUZUKI, RYUICHI HIRAYAMA, NORIYUKI KIJIMA, FUMIAKI ISOHASHI, YUJI SEO, KEISUKE OTANI, HARUHIKO KISHIMA and KAZUHIKO OGAWA
    Anticancer Research June 2019, 39 (6) 2935-2940; DOI: https://doi.org/10.21873/anticanres.13423
  • You have access
    Outcomes of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Severe Cirrhosis and Ineligibility for Transplant
    VLADIMIR VALAKH, STEVEN GRESSWELL and ALEXANDER KIRICHENKO
    Anticancer Research December 2018, 38 (12) 6815-6820; DOI: https://doi.org/10.21873/anticanres.13054
  • You have access
    Comparison of Re-irradiation Outcomes for Charged Particle Radiotherapy and Robotic Stereotactic Radiotherapy Using CyberKnife for Recurrent Head and Neck Cancers: A Multi-institutional Matched-cohort Analysis
    HIDEYA YAMAZAKI, YUSUKE DEMIZU, TOMOAKI OKIMOTO, MIKIO OGITA, KENGO HIMEI, SATOAKI NAKAMURA, GEN SUZUKI, KEN YOSHIDA, TADAYUKI KOTSUMA and YASUO YOSHIOKA
    Anticancer Research October 2016, 36 (10) 5507-5514;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire